Recent Articles

The best foods high in potassium — and why you need them

How to protect your health in a power outage

Can juicing help you get more fruits and vegetables?

Physical therapy provides modest improvement for chronic low back pain

Scoliosis treatment: Can it help as you get older?

Kinesio taping offers only modest relief for musculoskeletal disorders

New resistance training guidance may simplify your workout

What factors speed up aging?

The problem with "classic" Lyme disease symptoms

Staying active throughout middle age may lower women's risk of dying early

Adam Kibel, MD, MHCM

Editorial Advisory Board Member, Harvard Health Publishing

Adam Kibel, MD, MHCM, is the chief of urology at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, and the Elliott Carr Cutler Professor of Surgery at Harvard Medical School. He received his BA and MD from Cornell University in 1987 and 1991 respectively. He then completed his residency at the Harvard Program in Urology (Longwood) in 1997, and a fellowship in urologic oncology at Johns Hopkins in 1999. In 2022, he received a master’s in health care management from Harvard University.

His practice focuses on minimally invasive approaches to urologic cancers. He has over 400 peer-reviewed publications, and has received grant support from multiple agencies, including the National Cancer Institute, the American Urologic Association, the American College of Surgeons, and the Department of Defense. The focus of his research is on identification and treatment of patients with aggressive genitourinary cancers though neoadjuvant therapy, improved imaging, and novel biomarkers.